Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among Non-alcoholic Fatty Liver Disease Patients

NCT03250572 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT03250572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03250572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Ferritin as a Non-invasive Marker in Prediction of Hepatic Fibrosis Among Non-alcoholic Fatty Liver Disease Patients
Lead sponsor
Ain Shams University
Phase
Observational
Overall status
Completed
Start date
June 30, 2015
Completion date
November 30, 2016
Enrollment
113 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic fatty liver disease